Assessment of On-time Vaccination Coverage in Population Subgroups: A Record Linkage Cohort Study
Overview
Authors
Affiliations
Reported infant vaccination coverage at age 12 months in Australia is >90%. On-time coverage of the 2-4-6 month schedule and coverage in specific populations is rarely reported. We conducted a population-based cohort study of 1.9 million Australian births, 1996-2012, combining individual birth and perinatal records with immunisation records through probabilistic linkage. We assessed on-time coverage across 13 demographic and perinatal characteristics of diphtheria-tetanus-pertussis vaccines (DTP) defined as vaccination 14 days prior to the scheduled due date, to 30 days afterwards. On-time DTP vaccination coverage in non-Aboriginal infants was 88.1% for the 2-month dose, 82.0% for 4-month dose, and 76.7% for 6-month dose; 3-dose coverage was 91.3% when assessed at 12 months. On-time DTP coverage for Aboriginal infants was 77.0%, 66.5%, and 61.0% for the 2-4-6 month dose; 3-dose coverage at 12 months was 79.3%. Appreciable differences in on-time coverage were observed across population subgroups. On-time coverage in non-Aboriginal infants born to mothers with ≥3 previous pregnancies was 62.5% for the 6-month dose (47.9% for Aboriginal infants); up to 23.5 percentage points lower than for first-borns. Infants born to mothers who smoked during pregnancy had coverage 8.7-10.3 percentage points lower than infants born to non-smoking mothers for the 4- and 6-month dose. A linear relationship was apparent between increasing socio-economic disadvantage and decreasing on-time coverage. On-time coverage of the 2-4-6 month schedule is only 50-60% across specific population subgroups representing a significant avoidable public health risk. Aboriginal infants, multiparous mothers, and those who are socio-economically disadvantaged are key groups most likely to benefit from targeted programs addressing vaccine timeliness.
Geta Hardido T, Atinafu Ataro B, Elifios E Glob Pediatr Health. 2024; 11:2333794X241297034.
PMID: 39610854 PMC: 11603463. DOI: 10.1177/2333794X241297034.
Havelka E, Sanfilippo J, Juneau P, Sherman G, Cooper D, Leggio L Alcohol Alcohol. 2024; 59(6).
PMID: 39371015 PMC: 11456869. DOI: 10.1093/alcalc/agae057.
Agimas M, Belew A, Sisay M, Baffa L, Gashaw M, Abriham Z PLoS One. 2024; 19(4):e0301409.
PMID: 38578785 PMC: 10997123. DOI: 10.1371/journal.pone.0301409.
Agimas M, Asmamaw M, Mekonen N, Mamo F, Shewaye D PLoS One. 2024; 19(2):e0296123.
PMID: 38324535 PMC: 10849225. DOI: 10.1371/journal.pone.0296123.
Jayasundara D, Randall D, Sheridan S, Sheppeard V, Liu B, Richmond P Int J Epidemiol. 2022; 52(1):250-259.
PMID: 36099159 PMC: 9908038. DOI: 10.1093/ije/dyac175.